Childhood cancers: open trials in Denmark

99 open trials have a site in Denmark. Registry data; only the trial team decides who can take part.

2026-525234-39-00
A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1 · Janssen Cilag International
Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Registry updated 2026-11-06
NCT05533775
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Trial Treatment · Phase 1/2 · Hoffmann-La Roche
Rigshospitalet, København Ø
Registry updated 2026-11-05
2023-504264-41-00
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Trial Treatment · Phase 1/2 · F. Hoffmann-La Roche AG
Rigshospitalet, Copenhagen Oe
Registry updated 2026-11-04
NCT03340506
Dabrafenib and/or Trametinib Rollover Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Rigshospitalet, Copenhagen Oe
Registry updated 2026-11-03
NCT04924075
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Rigshospitalet (Site 0304), Copenhagen · Rigshospitalet-Department of Endocrinology (Site 0303), Copenhagen · Odense Universitetshospital (Site 0302), Odense C
Registry updated 2026-11-03
NCT06905587
Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue
Trial Treatment · Phase 3 · Odense University Hospital
Aarhus Universitetshospital, Aarhus N · Rigshospitalet, Copenhagen Oe · Region Nordjylland, Gistrup · Odense University Hospital, Odense C
Registry updated 2026-11-03
NCT03435796
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Trial Treatment · Phase 2/3 · Celgene
Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C · Region Sjaelland, Roskilde
Registry updated 2026-11-02
NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Rigshospitalet, Copenhagen Oe
Registry updated 2026-10-30
NCT07570173
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC
Aalborg University Hospital, Aalborg · Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Registry updated 2026-10-30
NCT07630974
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Rigshospitalet, Copenhagen Oe
Registry updated 2026-10-30
NCT07700758
A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Region Hovedstaden, Copenhagen Oe
Registry updated 2026-10-30
NCT04855656
Study of Lunresertib Alone or in Combination With RP-3500 or Zedoresertib (Debio 0123) in Patients With Advanced Solid Tumors
Trial Treatment · Phase 1 · Debiopharm International SA
Rigshospitalet, Copenhagen Oe
Registry updated 2026-10-28
NCT06367725
Pharmacokinetics of Dexamethasone in Childhood ALL and Reduction in Bone Mineral Density
Research · University of Aarhus
Department of Paediatrics and Adolescent Medicine, Aalborg University Hospital, Aalborg · Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus N · Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen · Department of Paediatrics and Adolescent Medicine, Odense University Hospital, Odense
Registry updated 2026-10-26
NCT07476729
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Trial Treatment · Phase 3 · Charite University, Berlin, Germany
Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Registry updated 2026-10-26
NCT07871864
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris
Aarhus University Hospital, Department of Paediatric and Adolescent Medicine, Aarhus · Aarhus University Hospital, Department of Oncology, Aarhus · Rigshospitalet, Copenhagen University Hospital, Department of Paediatric and Adolescent Medicine, Copenhagen · Herlev Hospital, Department of Oncology, Herlev
Registry updated 2026-10-26
NCT07155226
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Trial Treatment · Phase 1/2 · AstraZeneca
Rigshospitalet, Copenhagen Oe
Registry updated 2026-10-23
2022-501454-11-00
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
Trial Treatment · Phase 3 · GPOH gGmbH
Aalborg University Hospital, Aalborg · Aarhus University Hospital, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Registry updated 2026-10-21
NCT05476939
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris
Aarhus University Hospital, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Registry updated 2026-10-21
NCT06802991
Optimised Post-discharge Care in Older Patients After Surgery for Colon Cancer (ERAS 3.0)
Trial Treatment · Copenhagen University Hospital at Herlev
University Hospital Herlev, Herlev
Registry updated 2026-10-21
NCT07291102
Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma
Trial Treatment · Phase 3 · Nationwide Children's Hospital
Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Registry updated 2026-10-20
NCT07297914
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
Trial Treatment · Phase 2/3 · Bambino Gesù Hospital and Research Institute
Rigshopsitalet, University Hospital, Copenhagen
Registry updated 2026-10-20
NCT05327894
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Trial Treatment · Phase 3 · Princess Maxima Center for Pediatric Oncology
Aarhus University, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Registry updated 2026-10-19
2023-506546-23-00
Teicoplanin as Infection Prophylaxis in Pediatric Acute Myeloid Leukemia (Pro-Teico study)
Trial Treatment · Phase 3 · Prinses Maxima Centrum voor Kinderoncologie B.V.
Aarhus Universitetshospital, Aarhus N · Rigshospitalet, Copenhagen Oe
Registry updated 2026-10-16
NCT01356290
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Trial Treatment · Phase 2 · Medical University of Vienna
Aalborg University Hospital, Aalborg · Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Registry updated 2026-10-13
NCT06276491
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Trial Treatment · Phase 1 · Xencor, Inc.
Herlev & Gentofte Hospital, Herlev
Registry updated 2026-10-09

All Childhood cancers trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error